-+ 0.00%
-+ 0.00%
-+ 0.00%

ALLOGENE THERAPEUTICS INC - SINGLE DOSE OF ALLO-316 ACHIEVES 31% RESPONSE RATE

Reuters·06/01/2025 14:45:00

Please log in to view news